Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
NCT ID: NCT00241280
Last Updated: 2016-03-24
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
504 participants
INTERVENTIONAL
2005-09-30
2006-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Comparison of Two Daily Disposable Contact Lenses.
NCT00775021
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
NCT03701516
Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear
NCT01669629
Vistakon Investigational Lens Worn as a Single Use Daily Wear
NCT01031004
Evaluation of a Johnson & Johnson Vision Care Investigational Contact Lens Compared to a Marketed Monthly Replacement Contact Lens
NCT02515994
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
etafilcon A contact lens being worn 7 days/6 nights.
etafilcon A
Test
galyfilcon A contact lens being worn 7 days/6 nights.
galyfilcon A
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
etafilcon A
galyfilcon A
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subject must read and sign the statement of informed consent and be provided with a copy of the form.
* Minimum of 7 days of successful lens wear
* Contact lens prescription requiring between -1.00 to -6.00 D spherical power
* Less than 1.00 D of astigmatism in either eye
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson Vision Care, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Steven S. Grant, OD
Costa Mesa, California, United States
Cole, Cole, and Krohn
Fresno, California, United States
Fukai and Associates
Louisville, Colorado, United States
Peter C. Donshik, MD
Bloomfield, Connecticut, United States
Dr. Ted Brink and Associates
Jacksonville, Florida, United States
Jack J. Yager, OD
Orlando, Florida, United States
Clayton Eye Center
Morrow, Georgia, United States
Eyecare Associates
Bloomington, Illinois, United States
Drs. Hawks, Besler & Rogers
Gardner, Kansas, United States
Lee Rigel
East Lansing, Michigan, United States
Univ Missouri at St. Louis, College of Optometry
St Louis, Missouri, United States
InSight Eyecare
Warrensburg, Missouri, United States
Drs. Quinn, Quinn and Associates
Athens, Ohio, United States
Central Ohio Eyecare
Columbus, Ohio, United States
Kenji Hamada, OD
Grants Pass, Oregon, United States
West Hills Vision Center
Moon Township, Pennsylvania, United States
Kenneth A. Young, OD
Brentwood, Tennessee, United States
Gary W. Jerkins, MD
Nashville, Tennessee, United States
Premier Vision
Amarillo, Texas, United States
Charles Wegman, OD
Carrollton, Texas, United States
Wishnow-Sugar Vision Group
Katy, Texas, United States
First Eye Care Plano
Plano, Texas, United States
Dr. William Bogus
Salt Lake City, Utah, United States
Scott Jens, OD
Middleton, Wisconsin, United States
Snowy Range Vision Center
Laramie, Wyoming, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR-1480
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.